Chrysler
Summary
NHTSA campaign 25V083: Chrysler recalled for a safety defect. A rearview image that does not display reduces the driver's visibility, increasing the risk of a crash.
Details
Source
nhtsa
External ID
25V083
Action Date
2025-02-13
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2022 Jeep Grand Cherokee and 2021-2022 Jeep Grand Cherokee L vehicles. The center stack upper display (DCSD) contains a transistor that may overheat and prevent the rearview camera image from displaying. As such, these vehicles fail to comply with the requirements of Federal Motor Vehicle Safety Standard (FMVSS) number 111, "Rear Visibility."
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle